These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8899248)

  • 21. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Keefe RS; Bilder RM; Davis SM; Harvey PD; Palmer BW; Gold JM; Meltzer HY; Green MF; Capuano G; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Davis CE; Hsiao JK; Lieberman JA; ;
    Arch Gen Psychiatry; 2007 Jun; 64(6):633-47. PubMed ID: 17548746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
    Stroup TS; Lieberman JA; McEvoy JP; Swartz MS; Davis SM; Capuano GA; Rosenheck RA; Keefe RS; Miller AL; Belz I; Hsiao JK;
    Am J Psychiatry; 2007 Mar; 164(3):415-27. PubMed ID: 17329466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning.
    Harvey PD; Patterson TL; Potter LS; Zhong K; Brecher M
    Am J Psychiatry; 2006 Nov; 163(11):1918-25. PubMed ID: 17074943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients with schizophrenia remember that an event has occurred, but not when.
    Rizzo L; Danion JM; van der Linden M; Grangé D
    Br J Psychiatry; 1996 Apr; 168(4):427-31. PubMed ID: 8730938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
    Woodward ND; Purdon SE; Meltzer HY; Zald DH
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):457-72. PubMed ID: 15784157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.
    Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2004 Sep; 161(9):1709-11. PubMed ID: 15337666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current pharmacotherapy of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic drug side effect issues in bipolar manic patients.
    Zarate CA
    J Clin Psychiatry; 2000; 61 Suppl 8():52-61; discussion 62-3. PubMed ID: 10811244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
    Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
    Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of clozapine and risperidone on spatial working memory in schizophrenia.
    McGurk SR; Carter C; Goldman R; Green MF; Marder SR; Xie H; Schooler NR; Kane JM
    Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E; Valsecchi P; Parrinello G;
    Schizophr Res; 2008 Jan; 98(1-3):55-65. PubMed ID: 17933497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER).
    Naber D; Peuskens J; Schwarzmann N; Goltz M; Krüger H; Lambert M; Haro JM
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1257-69. PubMed ID: 23953270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Side effects of antipsychotics in the elderly.
    Masand PS
    J Clin Psychiatry; 2000; 61 Suppl 8():43-9; discussion 50-1. PubMed ID: 10811243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Atypical antipsychotic drugs].
    Kahn RS
    Ned Tijdschr Geneeskd; 2000 Aug; 144(34):1627-30. PubMed ID: 10972052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.